Sponsored by
This is the announcement for an exciting conference the 2 days before the society of neurooncology conference. It is for medical people only.
PROPOSAL: 2015 CNS Anticancer Drug Development and Delivery Conference
Co-Sponsored by SNO and SCIDOT (Society for CNS Interstitial Delivery of Therapeutics)
· Dates: Wednesday and Thursday prior to SNO Annual Meeting
o General drug development and delivery talks, along with brain tumor applications scheduled on Wednesday and Thursday AM
o Non-brain tumor application talks scheduled on Thursday PM
o Reduces programmatic conflicts for SNO attendees
o Allows for inclusion of non-brain tumor oriented speakers and attendees
· Format: Invited talks, abstracts for oral and poster presentation
· Target Audience:
o Clinical scientists
§ Neurosurgeons
§ NeuroOncologists
§ Neurologists (particularly movement disorders)
§ Medical Oncologists
§ Radiation Oncologists
§ Neuroradiologists (including Nuclear Medicine)
o Laboratory and translational scientists focused on cancer, brain tumors, movement disorders, other neurological disorders and blood-brain-barrier physiology
o Device manufacturers
o Drug and biotechology manufacturers
o Pre- and postdoctoral trainees
· General Themes
o Pharmacology and the impact of the BBB
o Methods of performing direct and indirect pharmacokinetics and pharmacodynamics in the brain
o Pharmacological approaches to improving therapeutic delivery to the brain and brain tumors
o Intrathecal drug delivery
o Drug delivery via intracavitary approaches
o Convection enhanced drug delivery
§ Device development
§ Recent clinical trials for brain tumors
§ Recent clinical trials for non-neoplastic neurological disorders
o Therapeutic development for direct brain delivery
§ Viral vectors
§ Conventional and target drugs
§ Carriers (nanoparticles and liposomes)
o Clinical trial design and Regulatory considerations
· Potential sponsors
o Genentech
o Brainlab
o MRI Interventions
o Alcyone
o Infuseon Therapeutics
o Renishaw
o Armagen
o Amgen
o Biogen-Idec